Differences Between “Big Three Positive” and “Small Three Positive” in Hepatitis B
May 24, 2022
Source: Cainiu Health
Dr. Yang Ziqi
Introduction
The differences between “Big Three Positive” and “Small Three Positive” hepatitis B typically include variations in hepatitis B virus (HBV) serological marker test results, levels of viral replication activity, disease severity, treatment strategies, and infectious risk. If you experience any discomfort or symptoms, it is advisable to seek medical attention at a hospital promptly and follow your physician’s treatment recommendations. It is also recommended to ensure adequate sleep and avoid staying up late.
The differences between “Big Three-Positive” and “Small Three-Positive” chronic hepatitis B generally include: distinct results on hepatitis B virus (HBV) serological marker testing, different levels of viral replication activity, varying degrees of disease severity, different treatment strategies, and different risks of transmission. If you experience any discomfort or symptoms, promptly consult a healthcare provider at a hospital and follow their medical advice for appropriate management.
1. Differences in HBV Serological Marker Test Results
“Big Three-Positive” refers to positive results for hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antibody (anti-HBc) in the five-item HBV panel test. “Small Three-Positive” refers to positive results for HBsAg, hepatitis B e antibody (anti-HBe), and anti-HBc.
2. Differences in Viral Replication Activity
Patients with “Big Three-Positive” hepatitis B typically exhibit high levels of HBV replication, resulting in relatively high viral loads in the blood. In contrast, patients with “Small Three-Positive” hepatitis B usually demonstrate lower levels of viral replication and consequently lower circulating viral loads.
3. Differences in Disease Severity
If “Big Three-Positive” status persists long-term with active viral replication, it more readily triggers ongoing hepatic inflammation, thereby increasing the risk of developing severe liver disease. Patients with “Small Three-Positive” hepatitis B generally have a more stable clinical course; overall, their risk of disease progression is lower than that of “Big Three-Positive” patients—provided no viral mutations occur.
4. Differences in Treatment Strategies
For “Big Three-Positive” patients, treatment primarily focuses on suppressing viral replication, reducing viral load, and alleviating hepatic inflammation—commonly achieved using antiviral medications. For “Small Three-Positive” patients with normal liver function and low viral load, management may emphasize regular monitoring and follow-up rather than immediate antiviral therapy. However, if abnormal liver function tests, viral mutation, or other complications arise, prompt antiviral treatment becomes necessary.
5. Differences in Transmission Risk
“Big Three-Positive” patients exhibit highly active viral replication and elevated viral loads, conferring a higher risk of HBV transmission via blood exposure, mother-to-child transmission, and sexual contact. Close contacts—including family members and sexual partners—are therefore at greater risk of infection. “Small Three-Positive” patients are comparatively less infectious, posing a lower transmission risk to others; nevertheless, standard precautions remain essential.
In daily life, maintain healthy habits: ensure adequate sleep, avoid staying up late, cultivate a positive mindset, and minimize stress, anxiety, or irritability—all of which contribute to better overall health.
